KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Other financing activities: 2010-2013

Historic Other financing activities for Supernus Pharmaceuticals (SUPN) over the last 4 years, with Dec 2013 value amounting to $3.6 million.

  • Supernus Pharmaceuticals' Other financing activities rose 81.25% to $29,000 in Q3 2013 from the same period last year, while for Sep 2013 it was $6.8 million, marking a year-over-year increase of 124.83%. This contributed to the annual value of $3.6 million for FY2013, which is 39.99% down from last year.
  • Per Supernus Pharmaceuticals' latest filing, its Other financing activities stood at $3.6 million for FY2013, which was down 39.99% from $6.0 million recorded in FY2012.
  • In the past 5 years, Supernus Pharmaceuticals' Other financing activities registered a high of $6.0 million during FY2012, and its lowest value of -$2.0 million during FY2011.
  • Over the past 3 years, Supernus Pharmaceuticals' median Other financing activities value was $3.6 million (recorded in 2013), while the average stood at $2.6 million.
  • As far as peak fluctuations go, Supernus Pharmaceuticals' Other financing activities crashed by 246.25% in 2011, and later surged by 407.27% in 2012.
  • Yearly analysis of 4 years shows Supernus Pharmaceuticals' Other financing activities stood at $1.3 million in 2010, then crashed by 246.25% to -$2.0 million in 2011, then spiked by 407.27% to $6.0 million in 2012, then tumbled by 39.99% to $3.6 million in 2013.